An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001.

BACKGROUND Reports of coccidioidomycosis cases in Arizona have increased substantially. We investigated factors associated with the increase. METHODS We analyzed the National Electronic Telecommunications System for Surveillance (NETSS) data from 1998 to 2001 and used Geographic Information Systems (GIS) to map high-incidence areas in Maricopa County. Poisson regression analysis was performed to assess the effect of climatic and environmental factors on the number of monthly cases; a model was developed and tested to predict outbreaks. RESULTS The overall incidence in 2001 was 43 cases/100,000 population, a significant (P<.01, test for trend) increase from 1998 (33 cases/100,000 population); the highest age-specific rate was in persons > or =65 years old (79 cases/100,000 population in 2001). Analysis of NETSS data by season indicated high-incidence periods during the winter (November-February). GIS analysis showed that the highest-incidence areas were in the periphery of Phoenix. Multivariable Poisson regression modeling revealed that a combination of certain climatic and environmental factors were highly correlated with seasonal outbreaks (R2=0.75). CONCLUSIONS Coccidioidomycosis in Arizona has increased. Its incidence is driven by seasonal outbreaks associated with environmental and climatic changes. Our study may allow public-health officials to predict seasonal outbreaks in Arizona and to alert the public and physicians early, so that appropriate preventive measures can be implemented.

[1]  J. J. Yu,et al.  A vaccine against coccidioidomycosis is justified and attainable. , 2004, Medical mycology.

[2]  D. Dennis,et al.  Coccidioidomycosis among Workers at an Archeological Site, Northeastern Utah , 2004, Emerging infectious diseases.

[3]  Korine N. Kolivras,et al.  Modeling valley fever (coccidioidomycosis) incidence on the basis of climate conditions , 2003, International journal of biometeorology.

[4]  G. Sanders,et al.  Cost-effectiveness of a potential vaccine for Coccidioides immitis. , 2001, Emerging infectious diseases.

[5]  B. Plikaytis,et al.  Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995–1996 , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  D. Pappagianis,et al.  Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities. , 2001, Fungal genetics and biology : FG & B.

[7]  C. Woods,et al.  Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. , 2000, The Journal of infectious diseases.

[8]  N. Ampel,et al.  Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. , 2000, The Journal of infectious diseases.

[9]  M. Fisher,et al.  Pathogenic Clones versus Environmentally Driven Population Increase: Analysis of an Epidemic of the Human Fungal PathogenCoccidioides immitis , 2000, Journal of Clinical Microbiology.

[10]  D. Pappagianis,et al.  Coccidioidomycosis in travelers returning from Mexico--Pennsylvania, 2000. , 2000, MMWR. Morbidity and mortality weekly report.

[11]  D. Pappagianis,et al.  Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Galgiani Coccidioidomycosis: A Regional Disease of National Importance: Rethinking Approaches for Control , 1999, Annals of Internal Medicine.

[13]  N. Ampel,et al.  Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  G. A. Marshall,et al.  A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. , 1997, JAMA.

[15]  Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[16]  J. Fierer,et al.  Coccidioidomycosis: a reemerging infectious disease. , 1996, Emerging infectious diseases.

[17]  R. Johnson,et al.  Coccidioidomycosis: new aspects of epidemiology and therapy. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  D. Pappagianis Epidemiology of coccidioidomycosis. , 1988, Current topics in medical mycology.

[19]  J. Galgiani,et al.  Coccidioidomycosis at a university health service. , 1985, The American review of respiratory disease.

[20]  C. Palmer,et al.  Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and to histoplasmin. , 1957, Diseases of the chest.

[21]  Homer G. Rosenberger,et al.  Effect of season and dust control on coccidioidomycosis. , 1946, Journal of the American Medical Association.

[22]  R. Beard,et al.  Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases. , 1946, American journal of public health and the nation's health.